Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Becker

Showing results (191-200 of 283) with videos related to

Pageof 29
Sort By:
Urologic Oncology|April 2, 2016
Trends of acute kidney injury after radical or partial nephrectomy for renal cell carcinomaMarianne Schmid, Nandita Krishna, Praful Ravi, et al.
Journal of Endourology|November 10, 2022
Which Men Do or Do Not Achieve Long-Term Symptom Relief After Holmium Laser Enucleation of the Prostate (HoLEP): 11 Years of HoLEP ExperiencePhilipp Gild, Malte W Vetterlein, Ihab Daoud, et al.
Journal of Endourology|February 7, 2014
Is robot-assisted radical prostatectomy safe in men with high-risk prostate cancer? Assessment of perioperative outcomes, positive surgical margins, and use of additional cancer treatmentsGiorgio Gandaglia, Firas Abdollah, Jim Hu, et al.
BJU International|September 24, 2013
Functional and oncological outcomes of patients aged <50 years treated with radical prostatectomy for localised prostate cancer in a European populationAndreas Becker, Pierre Tennstedt, Jens Hansen, et al.
International Journal of Radiation Oncology, Biology, Physics|September 26, 2023
A Phase 1 Study of the DNA-PK Inhibitor Peposertib in Combination With Radiation Therapy With or Without Cisplatin in Patients With Advanced Head and Neck TumorsMichael Samuels, Johan Falkenius, Voichita Bar-Ad, et al.
Frontiers in Oncology|October 27, 2022
An external validation of the nocera nomogram: Predicting non-organ confined stage of ≥pT3 in cT1 clear cell renal cell carcinomaMike Wenzel, Benedikt Hoeh, Jessica Rührup, et al.
The Prostate|October 11, 2021
Survival rates with external beam radiation therapy in newly diagnosed elderly metastatic prostate cancer patientsMike Wenzel, Claudia Collà Ruvolo, Christoph Würnschimmel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2023
A Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal CancerPaul B Romesser, Jaume Capdevila, Rocio Garcia-Carbonero, et al.
Frontiers in Oncology|May 10, 2021
Impact of Time to Castration Resistance on Survival in Metastatic Hormone Sensitive Prostate Cancer Patients in the Era of Combination TherapiesMike Wenzel, Felix Preisser, Benedikt Hoeh, et al.
The Journal of Urology|April 16, 2013
Incidence of priapism in emergency departments in the United StatesFlorian Roghmann, Andreas Becker, Jesse D Sammon, et al.
Pageof 29

Showing results (191-200 of 283) with videos related to

Sort By:
Pageof 29
Urologic Oncology|April 2, 2016
Trends of acute kidney injury after radical or partial nephrectomy for renal cell carcinomaMarianne Schmid, Nandita Krishna, Praful Ravi, et al.
Journal of Endourology|November 10, 2022
Which Men Do or Do Not Achieve Long-Term Symptom Relief After Holmium Laser Enucleation of the Prostate (HoLEP): 11 Years of HoLEP ExperiencePhilipp Gild, Malte W Vetterlein, Ihab Daoud, et al.
Journal of Endourology|February 7, 2014
Is robot-assisted radical prostatectomy safe in men with high-risk prostate cancer? Assessment of perioperative outcomes, positive surgical margins, and use of additional cancer treatmentsGiorgio Gandaglia, Firas Abdollah, Jim Hu, et al.
BJU International|September 24, 2013
Functional and oncological outcomes of patients aged <50 years treated with radical prostatectomy for localised prostate cancer in a European populationAndreas Becker, Pierre Tennstedt, Jens Hansen, et al.
International Journal of Radiation Oncology, Biology, Physics|September 26, 2023
A Phase 1 Study of the DNA-PK Inhibitor Peposertib in Combination With Radiation Therapy With or Without Cisplatin in Patients With Advanced Head and Neck TumorsMichael Samuels, Johan Falkenius, Voichita Bar-Ad, et al.
Frontiers in Oncology|October 27, 2022
An external validation of the nocera nomogram: Predicting non-organ confined stage of ≥pT3 in cT1 clear cell renal cell carcinomaMike Wenzel, Benedikt Hoeh, Jessica Rührup, et al.
The Prostate|October 11, 2021
Survival rates with external beam radiation therapy in newly diagnosed elderly metastatic prostate cancer patientsMike Wenzel, Claudia Collà Ruvolo, Christoph Würnschimmel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2023
A Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal CancerPaul B Romesser, Jaume Capdevila, Rocio Garcia-Carbonero, et al.
Frontiers in Oncology|May 10, 2021
Impact of Time to Castration Resistance on Survival in Metastatic Hormone Sensitive Prostate Cancer Patients in the Era of Combination TherapiesMike Wenzel, Felix Preisser, Benedikt Hoeh, et al.
The Journal of Urology|April 16, 2013
Incidence of priapism in emergency departments in the United StatesFlorian Roghmann, Andreas Becker, Jesse D Sammon, et al.
Pageof 29